Falcon Hospice, L.P.
- Sep 22, 2026 · D/A · $20,380,090 sold of Indefinite · 145 investors · min. No minimum reported · role: Director (Director of general partner of Issuer.) EDGAR ↗
- Sep 22, 2025 · D/A · $19,380,090 sold of Indefinite · 106 investors · min. No minimum reported · role: Director (Director of general partner of Issuer.) EDGAR ↗
- Sep 19, 2024 · D/A · $19,380,090 sold of Indefinite · 95 investors · min. No minimum reported · role: Director (Director of general partner of Issuer.) EDGAR ↗
- Sep 22, 2023 · D/A · $15,380,090 sold of Indefinite · 66 investors · min. No minimum reported · role: Director (Director of general partner of Issuer.) EDGAR ↗
Raised $20.4M from 145 investors as of the latest filing. Christopher is listed as director on 4 filings for this deal.
Sources
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.